-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Buy on Adient, Lowers Price Target to $22

Benzinga·11/06/2026 00:59:15
Listen to the news
UBS analyst Joseph Spak maintains Adient (NYSE:ADNT) with a Buy and lowers the price target from $23 to $22.